| 股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
| BHC Bausch Health Companies Inc. | 21,781,114,808.6 | 19,277,912,061.94 | 17,099,800,581.08 |
| TSHA Taysha Gene Therapies, Inc. | -1,314,181,442.0 | -1,314,148,932.87 | 5,729,115,886.32 |
| 6472 保瑞 | 688,938,000 | 454,238,000 | 3,696,457,000 |
| AMPH Amphastar Pharmaceuticals, Inc. | 1,668,498,412.59 | 1,389,212,506.14 | 1,712,418,242.6 |
| PSNL Personalis, Inc. | -837,760,191.97 | -960,709,708.69 | 662,340,944.94 |
| 3705 永信 | 327,770,000 | 208,390,000 | 563,414,000 |
| SLGL SOL-GEL TECHNOLOGIES LTD. | -279,155,869.94 | -278,570,705.66 | 457,403,410.98 |
| 1795 美時 | 701,365,000 | 603,443,000 | 150,870,000 |
| 6461 益得 | -85,138,000 | -98,472,000 | 44,980,000 |
| ASMB Assembly Biosciences Inc | -503,501,352.47 | -503,501,352.47 | 37,905,641.59 |
| CPHI China Pharma Holdings Inc | -1,067,274.63 | 4,434,244.87 | |
| 1720 生達 | 226,316,000 | 98,372,000 | -11,394,000 |
| 6130 上亞科技 | -9,023,000 | -9,023,000 | -13,697,000 |
| SUPN Supernus Pharmaceuticals, Inc. | -156,368,898.85 | -174,834,082.75 | -159,814,866.27 |
| 4120 友華 | -305,129,000 | -376,627,000 | -185,264,000 |
| 4747 強生* | 14,405,000 | 2,196,000 | -765,190,000 |
| RDY Dr. Reddy's Laboratories Limited | -318,687,780.59 | -1,496,491,811.13 | -1,433,235,552.63 |
| TEVA Teva Pharmaceutical Industries Limited | 13,393,760,150.96 | 9,980,301,860.06 | -2,795,784,885.88 |
| BBIO BridgeBio Pharma, Inc. | -2,311,431,408.96 | -2,325,832,952.04 | -6,566,258,404.88 |
載入數據中...
最新要聞
和學名藥相關的產業概念股
學名藥概念股相關指標排名
學名藥每月營收
學名藥每股盈餘
學名藥每股淨值
學名藥損益表
學名藥總資產
學名藥負債和股東權益
學名藥現金流量表
學名藥利潤比率
學名藥營業費用率拆解
學名藥杜邦分析
學名藥ROE / ROA
學名藥經營週轉能力
學名藥營運週轉天數
學名藥現金股利發放率
學名藥財務結構比率
學名藥流速動比率
學名藥利息保障倍數
學名藥現金流量分析
學名藥營業現金流對淨利比
學名藥盈餘再投資比率
學名藥月營收成長率
學名藥營收成長率
學名藥毛利成長率
學名藥營業利益成長率
學名藥稅後淨利成長率
學名藥每股盈餘成長率
學名藥本益比評價
學名藥股價淨值比評價
學名藥現金股利殖利率
學名藥平均現金股息殖利率
學名藥董監持股比例
學名藥董監持股質押比例